124 related articles for article (PubMed ID: 1912294)
21. Formation of pyridinium species of haloperidol in human liver and brain.
Eyles DW; McGrath JJ; Pond SM
Psychopharmacology (Berl); 1996 Jun; 125(3):214-9. PubMed ID: 8815956
[TBL] [Abstract][Full Text] [Related]
22. Bioactivation of MPTP: reactive metabolites and possible biochemical sequelae.
Trevor AJ; Castagnoli N; Caldera P; Ramsay RR; Singer TP
Life Sci; 1987 Feb; 40(8):713-9. PubMed ID: 3492651
[TBL] [Abstract][Full Text] [Related]
23. Nitroindazole compounds inhibit the oxidative activation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxin to neurotoxic pyridinium cations by human monoamine oxidase (MAO).
Herraiz T; Arán VJ; Guillén H
Free Radic Res; 2009 Oct; 43(10):975-84. PubMed ID: 19669997
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of the oxidation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) to toxic pyridinium cations by monoamine oxidase (MAO) enzymes and its use to search for new MAO inhibitors and protective agents.
Herraiz T
J Enzyme Inhib Med Chem; 2012 Dec; 27(6):810-7. PubMed ID: 21992679
[TBL] [Abstract][Full Text] [Related]
25. P450-catalyzed vs. electrochemical oxidation of haloperidol studied by ultra-performance liquid chromatography/electrospray ionization mass spectrometry.
Mali'n TJ; Weidolf L; Castagnoli N; Jurva U
Rapid Commun Mass Spectrom; 2010 May; 24(9):1231-40. PubMed ID: 20391593
[TBL] [Abstract][Full Text] [Related]
26. MPP(+)-like neurotoxicity of a pyridinium metabolite derived from haloperidol: in vivo microdialysis and in vitro mitochondrial studies.
Rollema H; Skolnik M; D'Engelbronner J; Igarashi K; Usuki E; Castagnoli N
J Pharmacol Exp Ther; 1994 Jan; 268(1):380-7. PubMed ID: 8301579
[TBL] [Abstract][Full Text] [Related]
27. Monoamine oxidase B(MAO-B) is the major catalyst for 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) oxidation in human brain and other tissues.
Glover V; Gibb C; Sandler M
Neurosci Lett; 1986 Feb; 64(2):216-20. PubMed ID: 3083305
[TBL] [Abstract][Full Text] [Related]
28. Brain extraction of 4-(4-chlorophenyl)-1-[4-(4-fluorophenyl)-4-oxobutyl]pyridinium ion (HPP+), a neurotoxic metabolite of haloperidol: studies using [3H]HPP+.
Kawashima H; Iida Y; Kitamura Y; Kiyono Y; Magata Y; Saji H
Jpn J Pharmacol; 2002 Aug; 89(4):426-8. PubMed ID: 12233823
[TBL] [Abstract][Full Text] [Related]
29. 1-Methyl-4-phenyl-2,3-dihydropyridinium is transformed by ubiquinone to the selective nigrostriatal toxin 1-methyl-4-phenylpyridinium.
Shi H; Noguchi N; Xu Y; Niki E
FEBS Lett; 1999 Nov; 461(3):196-200. PubMed ID: 10567696
[TBL] [Abstract][Full Text] [Related]
30. Structure-activity study of the mechanism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced neurotoxicity. II. Evaluation of the biological activity of the pyridinium metabolites formed from the monoamine oxidase-catalyzed oxidation of MPTP analogs.
Youngster SK; Nicklas WJ; Heikkila RE
J Pharmacol Exp Ther; 1989 Jun; 249(3):829-35. PubMed ID: 2786565
[TBL] [Abstract][Full Text] [Related]
31. Mutagenicity of MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) and its metabolites.
Cashman JR
Toxicology; 1987 Feb; 43(2):173-82. PubMed ID: 2949395
[TBL] [Abstract][Full Text] [Related]
32. Studies on the 1-methyl-4-phenyl-2,3-dihydropyridinium species 2,3-MPDP+, the monoamine oxidase catalyzed oxidation product of the nigrostriatal toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
Peterson LA; Caldera PS; Trevor A; Chiba K; Castagnoli N
J Med Chem; 1985 Oct; 28(10):1432-6. PubMed ID: 3876442
[TBL] [Abstract][Full Text] [Related]
33. Studies on the cytochrome P-450 catalyzed ring alpha-carbon oxidation of the nigrostriatal toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
Ottoboni S; Carlson TJ; Trager WF; Castagnoli K; Castagnoli N
Chem Res Toxicol; 1990; 3(5):423-7. PubMed ID: 2133093
[TBL] [Abstract][Full Text] [Related]
34. A reactive metabolite of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine is formed in rat brain in vitro by type B monoamine oxidase.
Corsini GU; Pintus S; Bocchetta A; Piccardi MP; Del Zompo M
J Pharmacol Exp Ther; 1986 Aug; 238(2):648-52. PubMed ID: 3488394
[TBL] [Abstract][Full Text] [Related]
35. Oxidation products arising from the action of monoamine oxidase B on 1-methyl-4-benzyl-1,2,3,6-tetrahydropyridine, a nonneurotoxic analogue of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
Sablin SO; Krueger MJ; Bachurin SO; Solyakov LS; Efange SM; Singer TP
J Neurochem; 1994 May; 62(5):2012-6. PubMed ID: 8158148
[TBL] [Abstract][Full Text] [Related]
36. Involvement of hepatic aldehyde oxidase in conversion of 1-methyl-4-phenyl-2,3-dihydropyridinium (MPDP+) to 1-methyl-4-phenyl-5,6-dihydro-2-pyridone.
Yoshihara S; Ohta S
Arch Biochem Biophys; 1998 Dec; 360(1):93-8. PubMed ID: 9826433
[TBL] [Abstract][Full Text] [Related]
37. Studies on the oxidation of 1,4-disubstituted-1,2,3,6-tetrahydropyridines.
Castagnoli N; Castagnoli K; Magnin G; Kuttab S; Shang J
Drug Metab Rev; 2002 Aug; 34(3):533-47. PubMed ID: 12214665
[TBL] [Abstract][Full Text] [Related]
38. Metabolite profile resulting from the activation/inactivation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 2-methyltetrahydro-β-carboline by oxidative enzymes.
Herraiz T; Guillén H; Galisteo J
Biomed Res Int; 2013; 2013():248608. PubMed ID: 23984327
[TBL] [Abstract][Full Text] [Related]
39. On the metabolism of haloperidol.
Gorrod JW; Fang J
Xenobiotica; 1993 May; 23(5):495-508. PubMed ID: 8342297
[TBL] [Abstract][Full Text] [Related]
40. In vitro metabolism of haloperidol and sila-haloperidol: new metabolic pathways resulting from carbon/silicon exchange.
Johansson T; Weidolf L; Popp F; Tacke R; Jurva U
Drug Metab Dispos; 2010 Jan; 38(1):73-83. PubMed ID: 19812350
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
